Literature DB >> 24189576

The immunobiology of prion diseases.

Adriano Aguzzi1, Mario Nuvolone, Caihong Zhu.   

Abstract

Individuals infected with prions succumb to brain damage, and prion infections continue to be inexorably lethal. However, many crucial steps in prion pathogenesis occur in lymphatic organs and precede invasion of the central nervous system. In the past two decades, a great deal has been learnt concerning the cellular and molecular mechanisms of prion lymphoinvasion. These properties are diagnostically useful and have, for example, facilitated preclinical diagnosis of variant Creutzfeldt-Jakob disease in the tonsils. Moreover, the early colonization of lymphoid organs can be exploited for post-exposure prophylaxis of prion infections. As stromal cells of lymphoid organs are crucial for peripheral prion infection, the dedifferentiation of these cells offers a powerful means of hindering prion spread in infected individuals. In this Review, we discuss the current knowledge of the immunobiology of prions with an emphasis on how basic discoveries might enable translational strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24189576     DOI: 10.1038/nri3553

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  186 in total

1.  Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie.

Authors:  N A Mabbott; F Mackay; F Minns; M E Bruce
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

2.  Transepithelial prion transport by M cells.

Authors:  F L Heppner; A D Christ; M A Klein; M Prinz; M Fried; J P Kraehenbuhl; A Aguzzi
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

3.  Postexposure prophylaxis against prion disease with a stimulator of innate immunity.

Authors:  Shneh Sethi; Grayson Lipford; Hermann Wagner; Hans Kretzschmar
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

4.  Disease-associated PrP in the enteric nervous system of scrapie-affected Suffolk sheep.

Authors:  Ragna Heggebø; Lorenzo González; Charles McL Press; Gjermund Gunnes; Arild Espenes; Martin Jeffrey
Journal:  J Gen Virol       Date:  2003-05       Impact factor: 3.891

5.  An analytical solution to the kinetics of breakable filament assembly.

Authors:  Tuomas P J Knowles; Christopher A Waudby; Glyn L Devlin; Samuel I A Cohen; Adriano Aguzzi; Michele Vendruscolo; Eugene M Terentjev; Mark E Welland; Christopher M Dobson
Journal:  Science       Date:  2009-12-11       Impact factor: 47.728

6.  Generating a prion with bacterially expressed recombinant prion protein.

Authors:  Fei Wang; Xinhe Wang; Chong-Gang Yuan; Jiyan Ma
Journal:  Science       Date:  2010-01-28       Impact factor: 47.728

7.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

8.  Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner.

Authors:  Jan Kranich; Nike Julia Krautler; Jeppe Falsig; Boris Ballmer; Shulei Li; Gregor Hutter; Petra Schwarz; Rita Moos; Christian Julius; Gino Miele; Adriano Aguzzi
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

Review 9.  Antiprion immunotherapy: to suppress or to stimulate?

Authors:  Adriano Aguzzi; Christina J Sigurdson
Journal:  Nat Rev Immunol       Date:  2004-09       Impact factor: 53.106

10.  Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles.

Authors:  Christopher A Baker; Daniel Martin; Laura Manuelidis
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more
  69 in total

1.  Post-conversion sialylation of prions in lymphoid tissues.

Authors:  Saurabh Srivastava; Natallia Makarava; Elizaveta Katorcha; Regina Savtchenko; Reinhard Brossmer; Ilia V Baskakov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

Review 2.  Microglia in prion diseases.

Authors:  Adriano Aguzzi; Caihong Zhu
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

Review 3.  Prion-Like Protein Aggregates and Type 2 Diabetes.

Authors:  Abhisek Mukherjee; Claudio Soto
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

Review 4.  Assembly and regulation of ASC specks.

Authors:  Florian Hoss; Juan F Rodriguez-Alcazar; Eicke Latz
Journal:  Cell Mol Life Sci       Date:  2016-10-19       Impact factor: 9.261

Review 5.  Follicular dendritic cells: dynamic antigen libraries.

Authors:  Balthasar A Heesters; Riley C Myers; Michael C Carroll
Journal:  Nat Rev Immunol       Date:  2014-06-20       Impact factor: 53.106

6.  Toxicant-mediated redox control of proteostasis in neurodegeneration.

Authors:  Stefanos Aivazidis; Colin C Anderson; James R Roede
Journal:  Curr Opin Toxicol       Date:  2018-12-28

7.  IP10, KC and M-CSF Are Remarkably Increased in the Brains from the Various Strains of Experimental Mice Infected with Different Scrapie Agents.

Authors:  Jia Chen; Cao Chen; Chao Hu; Lian Liu; Ying Xia; Lin Wang; Wei Yang; Hai-Yan Wu; Wei Zhou; Kang Xiao; Qi Shi; Yuezhang Wu; Zhi-Bao Chen; Xiao-Ping Dong
Journal:  Virol Sin       Date:  2020-04-20       Impact factor: 4.327

8.  Limited understanding of the functional diversity of N-linked glycans as a major gap of prion biology.

Authors:  Ilia V Baskakov
Journal:  Prion       Date:  2017-03-21       Impact factor: 3.931

9.  Parsing disease-relevant protein modifications from epiphenomena: perspective on the structural basis of SOD1-mediated ALS.

Authors:  N D Schmitt; J N Agar
Journal:  J Mass Spectrom       Date:  2017-07       Impact factor: 1.982

10.  Knockout of fractalkine receptor Cx3cr1 does not alter disease or microglial activation in prion-infected mice.

Authors:  James F Striebel; Brent Race; James A Carroll; Katie Phillips; Bruce Chesebro
Journal:  J Gen Virol       Date:  2016-03-02       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.